Pharma Equity Group A/S
CSE:PEG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Soosung Salvacion Co Ltd
KOSDAQ:084180
|
KR |
|
Stelco Holdings Inc
TSX:STLC
|
CA |
|
W
|
White Horse Bhd
KLSE:WTHORSE
|
MY |
|
Endurance Motive SA
MAD:END
|
ES |
|
F
|
Finnair Oyj
OMXH:FIA1S
|
FI |
|
Beam Therapeutics Inc
NASDAQ:BEAM
|
US |
|
Simonds Group Ltd
ASX:SIO
|
AU |
|
E
|
Eightco Holdings Inc
NASDAQ:OCTO
|
US |
|
S
|
Sichuan Zigong Conveying Machine Group Co Ltd
SZSE:001288
|
CN |
|
Uranium Energy Corp
XETRA:U6Z
|
US |
|
T
|
Tyme Technologies Inc
F:RFL
|
US |
|
Z
|
Ziga Innovation PCL
SET:ZIGA
|
TH |
|
Sera Prognostics Inc
NASDAQ:SERA
|
US |
|
Steadfast Group Ltd
ASX:SDF
|
AU |
|
V
|
Var Energi ASA
OSE:VAR
|
NO |
|
US Masters Residential Property Fund
ASX:URF
|
AU |
|
Coloplast A/S
CSE:COLO B
|
DK |
|
Cnb Community Bancorp Inc
OTC:CNBB
|
US |
Pharma Equity Group A/S
Research & Development
Pharma Equity Group A/S
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Pharma Equity Group A/S
CSE:PEG
|
Research & Development
-kr7.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Jeudan A/S
CSE:JDAN
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Copenhagen Capital A/S
CSE:CPHCAP ST
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
P
|
Prime Office A/S
CSE:PRIMOF
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Fast Ejendom Danmark A/S
CSE:FED
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
E
|
EgnsINVEST Ejendomme Tyskland A/S
CSE:EGNETY
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Pharma Equity Group A/S
Glance View
Pharma Equity Group A/S is a property company, which engages in the investment on real estates. The firm's purpose is, without geographical limitation, to be a holding company for companies with life science activities and to invest in shares admitted to trading on a regulated market place or multilateral trading facility and unlisted capital shares as determined by the board of directors in order to achieve long-term value growth while observing appropriate risk diversification as well as other related businesses.
See Also
What is Pharma Equity Group A/S's Research & Development?
Research & Development
-7.3m
DKK
Based on the financial report for Jun 30, 2025, Pharma Equity Group A/S's Research & Development amounts to -7.3m DKK.
What is Pharma Equity Group A/S's Research & Development growth rate?
Research & Development CAGR 1Y
22%
Over the last year, the Research & Development growth was 22%.
